Andrew C. Fish, JD
Andrew Fish is President & CEO of the Medical Device Innovation Consortium (MDIC). MDIC addresses complex challenges in medical technology regulatory science — the scientific and technical disciplines that drive medical technology research, development, and manufacturing and inform decision making for regulators, payers, health care providers, and patients. As a unique public-private partnership, MDIC’s members comprises medical technology manufacturers and key government agencies, including the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS).
Fish has an extensive record of solving high-stake challenges at the intersections of regulated business, health care, science, technology, law, media, and politics. Prior to joining MDIC in 2022, he held various roles at AdvaMed —the Advanced Medical Technology Association — including Chief Strategy Officer; the first Executive Director of the AdvaMed Center for Digital Health; Head of Sector Initiatives; and the first Executive Director of AdvaMedDx (AdvaMed’s in vitro diagnostics division). In his leadership roles with AdvaMed, Fish oversaw the association’s global and domestic
policy and advocacy agenda and launched specific organizational and issue initiatives, including AdvaMed’s Diabetes Sector, Radiation Therapy Sector, Cancer Forum, and the AdvaMed Data Stewardship and Privacy initiative.
Fish previously served as Senior Vice President of Legal and Government Affairs, General Counsel, and Secretary for the Consumer Healthcare Products Association. He has also led the American Cancer Society’s federal lobbying team as the Senior Director of Federal Government Relations; served in the Senate-confirmed post of Assistant Secretary of Agriculture for Congressional and Intergovernmental Affairs; and worked as Deputy Chief Counsel for the U.S. Senate Agriculture Committee. He holds a Bachelor of Arts from Yale University and a Juris Doctor degree from Stanford Law School.
Mike Golebiowski has over 20 years of marketing, product management, and entrepreneurial experience covering both pharmaceutical and medical devices. He currently leads B. Braun’s North America Healthcare Strategy and Innovations team, which includes a cross-functional incubator team with over 240 years of health care experience. Golebiowski previously led several start-up opportunities, placed first in the 2006 Burton D. Morgan Entrepreneurship competition, received the 2007 Gold Medical Design Excellence Award, and was featured in Business Week’s “Academia’s Brightest Tech Stars Out of Grad School.”
Golebiowski considers himself a bridge-builder between business and clinical experts in delivering practical programs and solutions that enhance patient care. He is an alumnus of the Wharton School of Business (2019); Purdue University (2006); and California State University, Fullerton (2000).
Mark Leahey is President and CEO of the Medical Device Manufacturers Association (MDMA), the leading national trade association that represents hundreds of innovative and entrepreneurial medical technology companies in Washington, DC. Some of his responsibilities include advocating on behalf of the medical device industry to Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and other federal and state agencies. Leahey has led efforts for more reasonable and predictable regulatory pathways for innovators and worked to open access in the hospital marketplace for all medical devices. He has also led efforts against the medical device tax when it was first proposed in 2009 and successfully advocated for multiple suspensions of the tax before securing a full repeal in 2019. Named one of the medical device industry’s top lobbyists, Leahey presently serves on the Board of Directors for the Fogarty Institute; the Executive Board of EXCITE International; and the Editorial Advisory Board of Medical Product Outsourcing.
Leahey is a member of the Massachusetts Bar. He is a graduate of Georgetown University, the Georgetown Law Center, and Georgetown’s McDonough School of Business.
Bruce T. Taylor
Bruce T. Taylor is a health care veteran with more than 40 years of experience in senior sales, marketing, health policy, Government Affairs, and advocacy positions with pharmaceutical manufacturers, chain pharmacies, managed care, and medical device manufacturers. He has extensive experience within numerous therapeutic areas including cardiovascular, gastrointestinal, burn care, diabetes, lipids, and CNS.
Taylor, who — in his prime — was a world class powerlifter and qualified for the 1980 Olympic games, co-founded the Diabetes Care Project with the National Minority Quality Forum to address the world-wide epidemic of diabetes and impact local, national, and global communities. He actively participates on advisory boards for the ADA, AACE, CWD, AADE, the Endocrine Society, National Minority Quality Forum, DPAC, Diabetes Leadership Council, and AMGF. Taylor is a highly regarded expert, prominent thought leader and speaker on topics like business implications and legislative impacts to the pharmaceutical and medical device industry.
Diabetes isn’t just a professional assignment for Taylor; he has lived with diabetes for
years after being diagnosed in 1980. Taylor earned a Bachelor of Science from Baldwin Wallace College and completed post-graduate work in cardiac physiology.
Rhoyge Traylor is an advocacy relations professional who excels in leveraging superior relationship-building skills to penetrate new markets. Presently the Senior Director of Global Patient Engagement at Edwards Lifesciences, Taylor is highly influential in his field and tenaciously expands access to relevant products through advocacy development and legislation with third-party organizations with his work. He is well-equipped to provide organizations with thoughtful public policy expertise that often leads to increased access and patient-centered results. Traylor held leadership positions at Pfizer, where he championed U.S. Policy and Public Affairs, and Amgen, as the Global Advocacy Relations Director, before joining Edwards Lifesciences. He has spent the last 12 years working directly with patient advocacy organizations — ensuring that the patient’s perspective is understood and incorporated throughout the company.
Randall “Randy” Rutta joined the National Health Council (NHC) in February 2021 as the organization’s CEO. Rutta leads the NHC, as it enters its second century, with the goal of affecting change across the entire health system and promote increased access to affordable, high-value, sustainable health care. The NHC brings diverse organizations together to forge consensus and drive patient-centered health policy, and Rutta inspires NHC staff to implement a Board-driven strategic plan, public policy, and advocacy efforts.
Prior to joining the NHC, Rutta was President & CEO of the American Autoimmune Related Disease Association (AARDA), a national organization dedicated to addressing the problem of autoimmunity. AARDA initiated and hosts the 40-member National Coalition of Autoimmune Patient Groups and is a longtime member of the NHC. He also served as AARDA’s Federal Policy Consultant. Before AARDA, Rutta served as President and CEO at Easterseals, a global nonprofit dedicated to the health, well-being, and success of people with disabilities, veterans, seniors, and families.
Rutta’s career experience has been in acute care, health care quality assurance, and health policy development and implementation. He holds a Master of Arts in Politics, with a focus on international health policy, from Catholic University of America in Washington, DC, and a Bachelor of Arts in Sociology from the University of Minnesota in Minneapolis.
Kim Zimmerman is Senior Vice President and Head of Federal Government Affairs for the Advanced Medical Technology Association (AdvaMed). In this role, she oversees the organization’s federal advocacy on behalf of medical technology companies across the United States. Prior to joining AdvaMed, Zimmerman honed her skills as a federal affairs expert through her role as Vice President of the American Health Care Association, where she commanded the group’s congressional Democratic lobbying team and spearheaded the development of the strategy for outreach and engagement. She has also held leadership positions at The One Campaign, WellPoint, and Cephalon, and spent nearly a decade on Capitol Hill working for Senators Tom Harkin (D-IA) and Ben Nelson (D-NE).
Zimmerman is a graduate of Drake University where she earned a degree in Political Science. From there, she graduated with a Master of Arts in Public Policy from Duke University.